CHICAGO (Reuters) May 22 – Healthcare products maker Johnson & Johnson reported new evidence on Wednesday that

05/23/2002 By James Adams  Losartan normalizes the response of the left main coronary artery to the cold

Special to DG News NEW YORK, NY — May 20, 2002 — Cardiac electrical instability — specifically

Special to DG News NEW YORK, NY — May 19, 2002 — The investigational selective aldosterone blocker,

Special to DG News NEW YORK, NY — May 19, 2002 — Perindopril erbumine appears to be

Special to DG News NEW YORK, NY — May 19, 2002 — Nighttime dosing with diltiazem hydrochloride

Special to DG News NEW YORK, NY — May 19, 2002 — Researchers report that controlled onset

Special to DG News NEW YORK, NY — May 19, 2002 —  More than 90 percent of

Laurie Barclay, MD NEW YORK (MedscapeWire) May 16 —  Microvascular disease may predict subsequent development of type

NEW YORK (Reuters Health) May 13 – In patients with coronary heart disease (CHD), total and LDL-cholesterol